Bristol-Myers Squibb Co.
Market cap $126.8B
$62.09
BMY
$62.09
+0.94% today
Buy with €1M virtual cash · No real money
Bristol-Myers Squibb Co. (BMY) is a publicly traded company listed on the XNYS. As of July 27, 2026, Invest's signal rates BMY a Buy, with the stock up 27% over the past year. You can practice trading BMY risk-free with €1,000,000 in virtual cash.
Key stats
As of July 27, 2026
Market Cap
$126.8B
Volume
12.1M
52-wk High
$62.89
52-wk Low
$42.52
Day High
$62.82
Day Low
$61.60
P/E (TTM)
18.00
Revenue (TTM)
$48.2B
EPS (TTM)
$3.45
Performance
1M
+12.9%
6M
+13.0%
1Y
+26.8%
Invest signal · BMY
BuyAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
BMY overview
AI overviewRevenue & EPS — last 8 quarters
QoQ rev +2.3%Revenue
$13BEPS (diluted)
$0.53 per shareLatest BMY news
Is Bristol Myers Squibb's Dividend Too Good to Be True? Here's My Honest Answer
The Motley Fool · 2d ago
Molecular Glues Clinical Trial Landscape: 80+ Emerging Competitors, Pipeline Dynamics, and Future Opportunities | DelveInsight
GlobeNewswire Inc. · 3d ago
Cathie Wood's $362 Million CRISPR Therapeutics Bet Isn't Just Bold -- It's Backed by a Catalyst Many Investors Are Underrating
The Motley Fool · 4d ago
Prediction: U.S. Value Stocks Will Outperform for 10 Years. Which ETFs Should You Buy?
The Motley Fool · 5d ago
Correction: Head and Neck Squamous Cell Carcinoma Market is Projected to Boost at a CAGR of 10.5% During the Forecast Period (2026–2036) Due to the Launch of Emerging Novel Immunotherapies | DelveInsight
GlobeNewswire Inc. · 5d ago
About Bristol-Myers Squibb Co.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Employees
32,500
30-Day Win Rate · BMY
14 days
9 days
Last 23 sessions
How to practice trading BMY
- 1
Use the BMY buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top BMY traders on Invest
Full leaderboardFrequently asked questions
Is BMY a good stock to buy right now?
As of July 27, 2026, Invest's signal rates BMY a Buy, based on its price trend, valuation, and fundamentals (P/E around 18.0), with the stock up 27% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading BMY risk-free first.
What is Bristol-Myers Squibb Co.'s (BMY) market cap?
Bristol-Myers Squibb Co. has a market capitalization of approximately $126.8B, on trailing-twelve-month revenue of about $48.2B.
How has BMY stock performed?
BMY is up 27% over the past year and up 13% over six months. Its 52-week range runs roughly from $42.52 to $62.89. Past performance doesn't predict future results.
How can I practice trading BMY for free?
On Invest you get €1,000,000 in virtual cash and can buy BMY at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare BMY with peers